OncoZenge AB (publ) announced that Dr. Paolo Bossi, Medical Oncologist and Associate Professor of Medical Oncology and Head of the Head and Neck Cancer Unit at the Humanitas University in Milan, Italy joins its Advisory Board. The OncoZenge Advisory Board was established in December 2023 with the objective of supporting the company in its efforts to lead BupiZenge(TM) through clinical development, market introduction and commercialization, with Dr. Stephen Sonis and Dr. Pooja Nandwani Patel as founding members. He is involved in all institutional research activities on head and neck cancer, from translational research (gene expression, next generation sequencing) to assessment of quality of life and value-based medicine.

He is particularly dedicated to rare cancer among head and neck cancers (paranasal sinus cancer, adnexal cancer, nasopharyngeal cancer, salivary gland cancer). He has strong experience with medical treatment of non-melanoma skin cancer, designing and conducting trials with targeted therapy and immunotherapy. He has a strong commitment to supportive care, specifically for what concerns mucositis induced by cancer therapies.

He collaborates with the Italian Network on Rare Tumors, a collaborative effort among Italian cancer centers, which tries to exploit distant patient sharing to improve quality of care and diminish health migration for rare solid cancers. He is the Principal Investigator and co-investigator of several Italian and International trials on Head and Neck cancer and non-melanoma skin cancer. Current responsibilities include; ESMO - Member of ESMO head and neck group and supportive and palliative care group, EORTC Head and Neck Group - Co-chair of the Older Adult Council at EORTC, MASCC - Chair of the Mucositis Study group for the period 2021-2024, AIOM (Italian Association of Medical Oncology), AIOCC (Italian Association of head and Neck Oncology), President of NICSO (Italian Network for Supportive Care in Oncology), Board of Director of GONO (Gruppo Oncologico Nord Ovest), Member of the SIOG Task Force on the Quality of Life in Older Cancer Patients, Member of the Head and Neck Cancer International Group Translational Research committee.